SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.
Emerg Microbes Infect
; 9(1): 2091-2093, 2020 Dec.
Article
em En
| MEDLINE
| ID: mdl-32930052
ABSTRACT
We studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in patients with severe disease. Likewise, mean antibody neutralization titers against SARS-CoV-2 pseudovirus and live virus were higher in the sicker patients, by â¼5-fold and â¼7-fold, respectively. These findings have important implications for those pursuing plasma therapy, isolation of neutralizing monoclonal antibodies, and determinants of immunity.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Nucleocapsídeo
/
Anticorpos Neutralizantes
/
Glicoproteína da Espícula de Coronavírus
/
Betacoronavirus
/
Anticorpos Antivirais
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Emerg Microbes Infect
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Estados Unidos